Elevated circulating level of β-aminoisobutyric acid (BAIBA) in heart failure patients with type 2 diabetes receiving sodium-glucose cotransporter 2 inhibitors

AIMS: The mechanism by which a sodium-glucose cotransporter inhibitor (SGLT2i) induces favorable effects on diabetes and cardiovascular diseases including heart failure (HF) remains poorly understood. Metabolomics including amino acid profiling enables detection of alterations in whole body metaboli...

Descripción completa

Detalles Bibliográficos
Autores principales: Katano, Satoshi, Yano, Toshiyuki, Kouzu, Hidemichi, Nagaoka, Ryohei, Numazawa, Ryo, Yamano, Kotaro, Fujisawa, Yusuke, Ohori, Katsuhiko, Nagano, Nobutaka, Fujito, Takefumi, Nishikawa, Ryo, Ohwada, Wataru, Katayose, Masaki, Sato, Tatsuya, Kuno, Atsushi, Furuhashi, Masato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768967/
https://www.ncbi.nlm.nih.gov/pubmed/36539818
http://dx.doi.org/10.1186/s12933-022-01727-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768967/
https://www.ncbi.nlm.nih.gov/pubmed/36539818
http://dx.doi.org/10.1186/s12933-022-01727-x

Ejemplares similares